Literature DB >> 29997164

BMP/SMAD Pathway and the Development of Dopamine Substantia Nigra Neurons.

Willemieke M Kouwenhoven1, Hendrikus J van Heesbeen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29997164      PMCID： PMC6596099          DOI： 10.1523/JNEUROSCI.0821-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  25 in total

1.  Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons.

Authors:  Pepijn van den Munckhof; Kelvin C Luk; Line Ste-Marie; Jane Montgomery; Pierre J Blanchet; Abbas F Sadikot; Jacques Drouin
Journal:  Development       Date:  2003-06       Impact factor: 6.868

2.  Pitx3 is required for development of substantia nigra dopaminergic neurons.

Authors:  Irene Nunes; Lucy T Tovmasian; Robert M Silva; Robert E Burke; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

3.  Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.

Authors:  B K Harvey; A Mark; J Chou; G J Chen; B J Hoffer; Y Wang
Journal:  Brain Res       Date:  2004-10-01       Impact factor: 3.252

Review 4.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

Review 5.  The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation.

Authors:  Allison M Bond; Oneil G Bhalala; John A Kessler
Journal:  Dev Neurobiol       Date:  2012-07       Impact factor: 3.964

6.  Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.

Authors:  Tetsuhiro Kikuchi; Asuka Morizane; Daisuke Doi; Hiroaki Magotani; Hirotaka Onoe; Takuya Hayashi; Hiroshi Mizuma; Sayuki Takara; Ryosuke Takahashi; Haruhisa Inoue; Satoshi Morita; Michio Yamamoto; Keisuke Okita; Masato Nakagawa; Malin Parmar; Jun Takahashi
Journal:  Nature       Date:  2017-08-30       Impact factor: 49.962

7.  Mediation of BMP7 neuroprotection by MAPK and PKC IN rat primary cortical cultures.

Authors:  Suyu Cox; Brandon K Harvey; Joseph F Sanchez; Jia-Yi Wang; Yun Wang
Journal:  Brain Res       Date:  2004-06-04       Impact factor: 3.252

8.  Dopamine neuron agenesis in Nurr1-deficient mice.

Authors:  R H Zetterström; L Solomin; L Jansson; B J Hoffer; L Olson; T Perlmann
Journal:  Science       Date:  1997-04-11       Impact factor: 47.728

9.  Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.

Authors:  Agnete Kirkeby; Sara Nolbrant; Katarina Tiklova; Andreas Heuer; Nigel Kee; Tiago Cardoso; Daniella Rylander Ottosson; Mariah J Lelos; Pedro Rifes; Stephen B Dunnett; Shane Grealish; Thomas Perlmann; Malin Parmar
Journal:  Cell Stem Cell       Date:  2016-10-27       Impact factor: 24.633

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.